RhumbLine Advisers’s Protalix BioTherapeutics PLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$145K Sell
2025
Q2
$103K Buy
2024
Q3
Sell
2024
Q2
$20.7K Sell
2024
Q1
$96.3K Buy
2023
Q4
$131K Sell
2023
Q3
$158K Buy
2023
Q2
$177K Buy